-
- Reimbursement Consulting, Healthcare Business Solutions
- Healthcare Market Research
- Healthcare Education, Healthcare Education And Training
- Hotline Assessments and Patient Assistance Programs
- Expanded Access Program
- Case Studies
- Market Research - Leveraging insight from Payors
- Comparative Cost Analysis - Pharmaceuticals
- Healthcare Reform Analysis
- Health Technology Assessment - Oncology
- Reimbursement Call Center and Patient Assistance Program Design - Multiple Product Classes
- Comparative Effectiveness Review - Diabetes
- Reimbursement Training and Field Reimbursement Call Tracking Tool
- Competitive Intelligence - Urology
- Product Commercialization and Reimbursement Landscape Analysis - Oncology
- Clinical Services Evaluation - Specialty Pharmacy
- Commercialization Strategy - Deep Vein Thrombosis
- Coverage Analysis - Drug Delivery System
- Reimbursement Coverage and Coding Analysis - Vascular Stents
- Health Economic Analysis - Rheumatoid Arthritis
- Health Economics Analysis - Diabetes Mellitus Blood Glucose Monitoring
- Expanded Access
- Comprehensive Clinical Analysis and Clinical Protocol Design - Migrane
- Outcomes Research Plan - Gastroenterology
- Clinical Compendium and Gap Analysis - Pain Management
- Reimbursement Landscape Analysis - Rare Bleeding Disorders (Hemophilia)
- Disease Area Review and Burden of Illness Analysis - Oncology
- Hospital Inpatient Payor Claims Analysis - Hospital Acquired Infections
- Health Economic Analysis - Orthopedics
- Market Valuation - Opioids
- Meta Analysis - HIV (Human Immunodeficiency Virus)
- AMCP Dossier - Dermatology
- Competitive Intelligence - Infectious Diseases
- Competitive Intelligence - Contraception
- Reimbursement Landscape Analysis - Urology
- Health Economics Analysis - Crohn's Disease
- Comprehensive Reimbursement and Health Economic Analysis - Neurovascular Disease
- Patient Assistance Program Design - Insulin Products
- Health Technology Assessment - Wound Therapy System
Case Studies
Health Economics Analysis - Crohn's Disease
Insight
A specialty pharmaceutical company, in its efforts to secure and sustain appropriate reimbursement for its product for mild to moderate Crohn’s disease, commissioned The Aequitas Group to undertake a cost-effectiveness analysis to support product positioning with commercial and government payors.Strategy
The Aequitas Group completed a health economics analysis (HEA) to support the reimbursement strategy for the product. The results helped determine the incremental cost-effectiveness of the client’s product compared to existing products already in the marketplace for the same indication, while revealing the price at which the client’s product would be the most cost-effective option.Execution
By completing a formal HEA, derived from on evidence-based methods used by commercial and government payors in the U.S., The Aequitas Group was able to provide the client with value messages to inform their comprehensive product positioning strategies.© 2009 The Aequitas Group, Inc. All Rights Reserved.